Tolulope Anthony AdekolaView profile
Research Fellow
Dr. Tolulope Anthony Adekola serves as a Research Fellow at the School of Law within the Faculty of Business, Economics and Law at The University of Queensland. His scholarly work bridges intellectual property law, international trade frameworks, and public health policy with specific emphasis on pharmaceutical patent systems and biotechnology regulation in developing contexts. His academic credentials include a PhD from the City University of Hong Kong (funded by the University Grants Committee of Hong Kong and Max Planck Institute), a German and European Law Certificate from Ludwig Maximilian University of Munich, and professional qualification as a Barrister and Solicitor of Nigeria's Supreme Court. PhD, City University of Hong Kong German and European Law Certificate, LMU Munich Barrister and Solicitor, Supreme Court of Nigeria Dr. Adekola's research confronts the tension between patent protection and equitable access to medicines, particularly through analysis of TRIPS flexibilities, regional cooperation mechanisms, and technology transfer frameworks. His scholarship demonstrates how pharmaceutical patent law intersects with sustainable development goals and public health imperatives in least developed countries, with recurring focus on mRNA technology, vaccine distribution, and African regional integration. His 15+ publications reveal consistent thematic progression: early work established foundations in TRIPS implementation and Doha Declaration mechanisms (2019-2020), evolving into pandemic-responsive analyses of vaccine nationalism and mRNA patent landscapes (2020-2023), culminating in current research on equitable technology transfer hubs and genome-editing regulation (2024-2025). The corpus consistently prioritizes practical policy solutions over theoretical debates. Scientific recognition includes: University Grants Committee of Hong Kong PhD Scholarship Max Planck Institute for Innovation and Competition PhD Fellowship Dr. Adekola has held teaching appointments at City University of Hong Kong and Landmark University, Nigeria. His current consultancy roles with the South African Research Chair in Industrial Development (University of Johannesburg) and United Nations Office of the Special Adviser on Africa demonstrate applied policy impact. Grant activities focus on pharmaceutical access projects funded by international institutions including the Max Planck Institute. His research operates at the nexus of academic scholarship and international policy development, maintaining active collaboration with the Max Planck Institute for Innovation and Competition and United Nations agencies to translate theoretical frameworks into actionable health and trade policies for developing economies.







